Literature DB >> 14900360

Tests of 2,4-diaminopyrimidines on toxoplasmosis.

D E EYLES, N COLEMAN.   

Abstract

Entities:  

Keywords:  PYRIMIDINES; TOXOPLASMOSIS/experimental

Mesh：

Substances：

Year:  1952        PMID： 14900360      PMCID： PMC2030727     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN： 0094-6214            Impact factor:   2.792


× No keyword cloud information.
  2 in total

1.  2:4-diaminopyrimidines- a new series of antimalarials.

Authors:  E A FALCO; L G GOODWIN; G H HITCHINGS; I M ROLLO; P B RUSSELL
Journal:  Br J Pharmacol Chemother       Date:  1951-06

2.  Potentiation of the antimalarial activity of sulfadiazine by 2,4-diamino-5-aryloxypyrimidines.

Authors:  J GREENBERG; E M RICHESON
Journal:  J Pharmacol Exp Ther       Date:  1950-08       Impact factor: 4.030
  2 in total
  4 in total

1.  Sulphonamides and folic acid antagonists in malaria and toxoplasmosis.

Authors:  L G GOODWIN
Journal:  Proc R Soc Med       Date:  1956-11

2.  Discovery of Potent and Selective Leads against Toxoplasma gondii Dihydrofolate Reductase via Structure-Based Design.

Authors:  Matthew E Welsch; Jian Zhou; Yueqiang Gao; Yunqing Yan; Gene Porter; Gautam Agnihotri; Yingjie Li; Henry Lu; Zhongguo Chen; Stephen B Thomas
Journal:  ACS Med Chem Lett       Date:  2016-09-17       Impact factor: 4.345

3.  Sulphadimidine, pyrimethamine and dapsone in the treatment of toxoplasmosis in mice.

Authors:  J K BEVERLEY; B A FRY
Journal:  Br J Pharmacol Chemother       Date:  1957-06

Review 4.  Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice.

Authors:  Ildiko Rita Dunay; Kiran Gajurel; Reshika Dhakal; Oliver Liesenfeld; Jose G Montoya
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.